Therapy-related leukemia and myelodysplasia: susceptibility and incidence

Leone, G.; Pagano, L.; Ben-Yehuda, D.; Voso, M. T.

doi:10.3324/haematol.11034

Cited by 236Acute Myeloid Leukemia ResearchMultiple and Secondary Primary CancersRetinoids in leukemia and cellular processes

Therapy-related leukemia and myelodysplasia: susceptibility and incidence

Open access

Leone, G., Pagano, L., Ben-Yehuda, D., Voso, M. T.·2007·Haematologica

DOI 10.3324/haematol.11034

Open this paper in CoChat — free account Open PDF

Abstract

Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recognized treatment complication in patients treated with radiotherapy or chemotherapy for previous hematologic malignancies or solid tumors. Distinct clinical entities have been described according to the primary treatment, corresponding to defined genetic lesions. Chromosome 7 and/or 5 losses or deletions are typical of alkylating agent-induced AML, while development of t-AML with balanced translocations involving chromosome bands 11q23 and 21q22 has been related to previous therapy with drugs targeting DNA-topoisomerase II. In addition, antimetabolites, and in particular the immunosuppressant azathioprine, have been shown to induce defective DNA-mismatch repair. This could promote survival of misrepaired cells giving rise to the leukemic clone. Individual predisposing factors, including polymorphisms in detoxification and DNA repair enzymes have been identified. Their combination may significantly increase the risk of t-MDS/AML. Among patients with hematologic malignancies, long-term survivors of Hodgkin's lymphoma are exposed to an increased risk of t-MDS/AML, particularly when receiving MOPP-based, and escalated BEACOPP regimens, and when alkylators are combined with radiotherapy. Patients with Hodgkin's and non-Hodgkin's lymphoma are at highest risk when total body irradiation followed by autologous stem cell transplantation is used as rescue or consolidation therapy. The addition of granulocyte-colony-stimulating factor and radiotherapy plays a significant role in t-AML following treatment of children with acute lymphoblastic leukemia. In non-hematologic malignancies, treatment for breast cancer and germ-cell tumors has been associated with a 1-5% lifetime risk of both lymphoid as well as myeloid leukemia. In all cases the risk of t-MDS/AML drops sharply by 10 years after treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3324/haematol.11034

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Secondary cancers are frequently acute myeloid leukaemias, which may be caused by previous exposure to DNA-damaging alkylators, often arising after a median of around 7 years after initial treatment.
“Secondary cancers are frequently acute myeloid leukaemias 155 , which may be caused by previous exposure to DNA-damaging alkylators, often arising after a median of around 7 years after initial treatment 158 .”
From Osteosarcoma (2022) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952 · see citing works
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia
Harrison, C. N., Campbell, P. J., Buck, G. A. N., Wheatley, K., East, C. L., Bareford, D., Wilkins, B. S., van der Walt, J. D., Reilly, J. T., Grigg, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043800 · Cited by 921 · see citing works
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
Smith, S. M., Beau, M. M. L., Huo, D., Karrison, T. G., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 681 · see citing works
Hematotoxicity in Workers Exposed to Low Levels of Benzene
Qing Lan, B., Zhang, L., Li, G., Vermeulen, R. C. H., Weinberg, R. S., Dosemeci, M., Rappaport, S. M., Shen, M., Alter, B. P., Wu, Y., et al. (2004) · Science · doi:10.1126/science.1102443 · Cited by 651 · see citing works
Environment and Cancer: Who Are Susceptible?
Perera, F. P. (1997) · Science · doi:10.1126/science.278.5340.1068 · Cited by 638 · see citing works
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study
Finazzi, G. (2004) · Blood · doi:10.1182/blood-2004-09-3426 · Cited by 433 · see citing works
Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes
Rushmore, T. H., & Kong, A.-N. T. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337171 · Cited by 425 · see citing works
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 415 · see citing works
Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion
Sterkers, Y., Preudhomme, C., Laï, J., Demory, J., Caulier, M. T., Wattel, E., Bordessoule, D., Bauters, F., & Fenaux, P. (1998) · Blood · doi:10.1182/blood.v91.2.616 · Cited by 369 · see citing works
Homologous repair of DNA damage and tumorigenesis:the BRCA connection
Jasin, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206176 · Cited by 356 · see citing works
Association of CYP 3 A 4 genotype with treatment-related leukemia
Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N. V., Lovett, B. D., Nowell̀, P. C., Blair, I. A., & Rebbeck, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13176 · Cited by 310 · see citing works
Prevalence of the Inactivating 609C→T Polymorphism in the NAD(P)H:Quinone Oxidoreductase (NQO1) Gene in Patients With Primary and Therapy-Related Myeloid Leukemia
Larson, R. A., Wang, Y., Banerjee, M., Wiemels, J. L., Hartford, C. M., Beau, M. M. L., & Smith, M. T. (1999) · Blood · doi:10.1182/blood.v94.2.803 · Cited by 304 · see citing works
Acute Myeloid Leukemia and Myelodysplastic Syndrome After Doxorubicin-Cyclophosphamide Adjuvant Therapy for Operable Breast Cancer: The National Surgical Adjuvant Breast and Bowel Project Experience
Smith, R. E., Bryant, J., DeCillis, A. P., & Anderson, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.114 · Cited by 299 · see citing works
Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy
Hershman, D. L., Neugut, A. I., Jacobson, J. S., Wang, J., Tsai, W., McBride, R. B., Bennett, C. L., & Grann, V. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk028 · Cited by 277 · see citing works
Polymorphism in glutathione S -transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
Allan, J. M., Wild, C. P., Rollinson, S. J., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., & Morgan, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191211198 · Cited by 268 · see citing works
Treatment-Associated Leukemia Following Testicular Cancer
Travis, L. B. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1165 · Cited by 256 · see citing works
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia
Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., & Nerlov, C. (2002) · Blood · doi:10.1182/blood.v99.6.1909 · Cited by 244 · see citing works
Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients
Armitage, J. O., Carbone, P. P., Connors, J. M., Levine, A. M., Bennett, J. M., & Kroll, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.113 · Cited by 224 · see citing works
Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie Pédiatrique
Deley, M. L., Leblanc, T. M., Shamsaldin, A., Raquin, M., Lacour, B., Sommelet, D., Chompret, A., Cayuela, J., Bayle, C., Bernheim, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.100 · Cited by 213 · see citing works
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
Gangat, N., Wolanskyj, A. P., McClure, R. F., Li, C.-Y., Schwager, S. M., Wu, W., & Tefferi, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404500 · Cited by 206 · see citing works
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
Metayer, C. (2002) · Blood · doi:10.1182/blood-2002-04-1261 · Cited by 202 · see citing works
Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105
Johansson, A.-S., Stenberg, G., Widersten, M., & Mannervik, B. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1708 · Cited by 189 · see citing works
Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide
Praga, C., Bergh, J. C. S., Bliss, J. M., Bonneterre, J. M., Cesana, B. M., Coombes, R. C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.029 · Cited by 187 · see citing works
Increased transcriptional activity of the CYP3A4*1B promoter variant
Amirimani, B., Ning, B., Deitz, A. C., Weber, B. L., Kadlubar, F. F., & Rebbeck, T. R. (2003) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10199 · Cited by 183 · see citing works
Thiopurines, DNA damage, DNA repair and therapy-related cancer
Karran, P. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl020 · Cited by 182 · see citing works
Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011
Morrison, V. A., Rai, K. R., Peterson, B. L., Kolitz, J. E., Elias, L., Appelbaum, F. R., Hines, J., Shepherd, L. E., Larson, R. A., & Schiffer, C. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.128 · Cited by 176 · see citing works
Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study
Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P., & Linch, D. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2200 · Cited by 172 · see citing works
Long‐term outcome results of the first tandem autotransplant trial for multiple myeloma
Barlogie, B., Tricot, G. J. K., van Rhee, F., Angtuaco, E., Walker, R., Epstein, J., Shaughnessy, J. D., Jagannath, S., Bolejack, V., Gurley, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06271.x · Cited by 164 · see citing works
Polymorphisms in Genes Involved in Homologous Recombination Repair Interact to Increase the Risk of Developing Acute Myeloid Leukemia
Seedhouse, C., Faulkner, R. D., Ashraf, N., Das-Gupta, E. P., & Russell, N. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0372 · Cited by 164 · see citing works
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
Bennett, J. M. (2005) · Blood · doi:10.1182/blood-2004-12-4690 · Cited by 160 · see citing works
Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group
Josting, A., Wiedenmann, S., Franklin, J. G., May, M., Sieber, M., Wolf, J., Engert, A., & Diehl, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.160 · Cited by 159 · see citing works
GlutathioneS-Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid Leukemia
Davies, S. M., Robison, L. L., Buckley, J. D., Tjoa, T., Woods, W. G., Radloff, G. A., Ross, J. A., & Perentesis, J. P. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1279 · Cited by 151 · see citing works
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
Relling, M. V., Boyett, J. M., Blanco, J. G., Raimondi, S. C., Behm, F. G., Sandlund, J. T., Rivera, G. K., Kun, L. E., Evans, W. E., & Pui, C. (2003) · Blood · doi:10.1182/blood-2002-08-2405 · Cited by 151 · see citing works
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients
André, M. P. E. (2003) · Blood · doi:10.1182/blood-2003-04-1124 · Cited by 151 · see citing works
Anthracyclines, Mitoxantrone, Radiotherapy, and Granulocyte Colony-Stimulating Factor: Risk Factors for Leukemia and Myelodysplastic Syndrome After Breast Cancer
Deley, M. L., Suzan, F., Cutuli, B., Delaloge, S., Shamsaldin, A., Linassier, C., Clisant, S., de Vathaire, F., Fenaux, P., & Hill, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9048 · Cited by 150 · see citing works
Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children
Smith, M. T., Wang, Y., Skibola, C. F., Slater, D. J., Nigro, L. L., Nowell̀, P. C., Lange, B. J., & Felix, C. A. (2002) · Blood · doi:10.1182/blood-2001-12-0264 · Cited by 141 · see citing works
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia
Kishi, S., Yang, W., Boureau, B., Morand, S. C., Das, S., Chen, P., Cook, E. H., Rosner, G. L., Schuetz, E. G., Pui, C., et al. (2003) · Blood · doi:10.1182/blood-2003-06-2105 · Cited by 130 · see citing works
Moderate Increase of Secondary Hematologic Malignancies After Myeloablative Radiochemotherapy and Autologous Stem-Cell Transplantation in Patients With Indolent Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group
Lenz, G., Dreyling, M. H., Schiegnitz, E., Haferlach, T., Hasford, J., Unterhalt, M., & Hiddemann, W. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.016 · Cited by 125 · see citing works
Therapy-related myelodysplastic syndrome–acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
Latagliata, R., Petti, M. C., Fenu, S., Mancini, M., Spiriti, M. A. A., Breccia, M., Brunetti, G. A., Avvisati, G., Lo‐Coco, F., & Mandelli, F. (2002) · Blood · doi:10.1182/blood.v99.3.822 · Cited by 123 · see citing works
Negative prognostic value of glutathione S-transferase(GSTM1 and GSTT1) deletions in adult acute myeloid leukemia
Voso, M. T., D’Alò, F., Putzulu, R., Mele, L., Scardocci, A., Chiusolo, P., Latagliata, R., Lo‐Coco, F., Rutella, S., Pagano, L., et al. (2002) · Blood · doi:10.1182/blood.v100.8.2703 · Cited by 123 · see citing works
Self-citation
Breast cancer and acute leukemia: Report of 24 cases and review of the literature
Rosner, F., Carey, R. W., & Zarrabi, M. H. (1978) · American Journal of Hematology · doi:10.1002/ajh.2830040207 · Cited by 109 · see citing works
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies
Blanco, J. G., Edick, M. J., Hancock, M. L., Winick, N. J., Dervieux, T., Amylon, M. D., Bash, R. O., Behm, F. G., Camitta, B. M., Pui, C., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00004 · Cited by 100 · see citing works
Second malignancies in children with neuroblastoma after combined treatment with 131I‐metaiodobenzylguanidine
Garaventa, A., Gambini, C., Villavecchia, G., Cataldo, A. D., Bertolazzi, L., Pizzitola, M. R., Bernardi, B. D., & Haupt, R. (2003) · Cancer · doi:10.1002/cncr.11167 · Cited by 95 · see citing works
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
McLaughlin, P. J., Estey, E. H., Glassman, A. B., Romaguera, J. E., Samaniego, F., Ayala, A. B., Hayes, K. J., Maddox, A. M., Preti, H. A., & Hagemeister, F. B. (2005) · Blood · doi:10.1182/blood-2004-08-3035 · Cited by 90 · see citing works
Cytochrome P450 and Anticancer Drugs
Fujita, K. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832587 · Cited by 90 · see citing works
Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients
Rund, D. G., Krichevsky, S., Cohen, S. B., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran‐Tikva, S., Ben‐Neriah, S., & Ben‐Yehuda, D. (2005) · Leukemia · doi:10.1038/sj.leu.2403947 · Cited by 80 · see citing works
Self-citation
Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients
Schonfeld, S. J., Gilbert, E. S., Dores, G. M., Lynch, C. F., Hodgson, D. C., Hall, P. N., Storm, H. H., Andersen, A., Pukkala, ., Holowaty, E. J., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj017 · Cited by 80 · see citing works
Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation
Barnard, D., Lange, B., Alonzo, T. A., Buckley, J. D., Kobrinsky, J. N., Gold, S., Neudorf, S. M. L., Sanders, J. E., Burden, L., & Woods, W. G. (2002) · Blood · doi:10.1182/blood.v100.2.427 · Cited by 78 · see citing works
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience
Lobe, I., Huguet, F., Vekhoff, A., Desablens, B., Bordessoule, D., Mounier, C., Ferrant, A., Sanz, M. Á., Fey, M. F., Chomienne, C., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403034 · Cited by 77 · see citing works
An Intron Splice Acceptor Polymorphism in hMSH2 and Risk of Leukemia after Treatment with Chemotherapeutic Alkylating Agents
Worrillow, L. J., Travis, L. B., Smith, A. G., Rollinson, S. J., Smith, A. J. P., Wild, C. P., Holowaty, E. J., Kohler, B., Wiklund, T. A., Pukkala, ., et al. (2003) · PubMed · doi:10.25405/ncl.34299504 · Cited by 76 · see citing works
Therapy-related myelodysplastic syndromes.
Dj, P., & Hp, K. (1996) · PubMed · Cited by 76 · see citing works
Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations
Tuimala, J., Szekely, G., Wikman, H., Järventaus, H., Hirvonen, A., Gundy, S., & Norppa, H. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.009 · Cited by 74 · see citing works
Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia
Pui, C., Pei, D., Sandlund, J. T., Campana, D., Ribeiro, R. C., Razzouk, B. I., Rubnitz, J. E., Howard, S. C., Hijiya, N., Jeha, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0033 · Cited by 71 · see citing works
Acute Myelogenous Leukemia After Treatment for Malignant Germ Cell Tumors in Children
Schneider, D. T., Hilgenfeld, E., Schwabe, D., Behnisch, W., Zoubek, A., Wessalowski, R., & Göbel, U. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3226 · Cited by 67 · see citing works
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino, E., Anselmo, A. P., Klersy, C., Santoro, M., Orlandi, E. M., PAGNUCCO, G., Lunghi, F., Maurizi-Enrici, R., Baroni, C. D., Lazzarino, M., et al. (1998) · PubMed · Cited by 66 · see citing works
Therapy-related myeloid leukaemia: A model for leukemogenesis in humans
Larson, R. A., & Beau, M. M. L. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.03.023 · Cited by 66 · see citing works
Fifteen‐year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high‐dose irradiation
Delwail, V., Jaïs, J., Colonna, P., & Andrieu, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03564.x · Cited by 66 · see citing works
Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia
Pagano, L., Pulsoni, A., Tosti, M. E., Avvisati, G., Mele, L., Mele, A., Martino, B., Visani, G., Cerri, R., Bona, E. D., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02527.x · Cited by 65 · see citing works
Self-citation
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1
Haase, D. T., Binder, C. R., Bünger, J., Fonatsch, C., Streubel, B., Schnittger, S., Griesinger, F., Westphal, G., Schoch, C., Knopp, A., et al. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00124-2 · Cited by 60 · see citing works
Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
Hake, C. R., Graubert, T. A., & Fenske, T. S. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705547 · Cited by 58 · see citing works
Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia
Sasai, Y., Horiike, S., Misawa, S., Kaneko, H., Kobayashi, M., Fujii, H., Kashima, K., & Taniwaki, M. (1999) · Leukemia Research · doi:10.1016/s0145-2126(99)00119-8 · Cited by 57 · see citing works
Leukemia following breast cancer: an international population-based study of 376,825 women
Howard, R. A., Gilbert, E. S., Chen, B. E., Hall, P. N., Storm, H. H., Pukkala, ., Langmark, F., Kaijser, M., Andersson, M., Joensuu, H., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9460-0 · Cited by 47 · see citing works
Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t‐AML/MDS
Fern, L. A., Pallis, M., Carter, G. I., Seedhouse, C., Russell, N. H., & Byrne, J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05006.x · Cited by 37 · see citing works
Hematotoxicity in Workers Exposed to Low Levels of Benzene
Lan, Q. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bg6f-8m46 · Cited by 31 · see citing works
Secondary Leukemias in Refractory Germ Cell Tumor Patients Undergoing Autologous Stem-Cell Transplantation Using High-Dose Etoposide
Houck, W., Abonour, R., Vance, G. H., & Einhorn, L. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.054 · Cited by 29 · see citing works
Prevalence of the Inactivating 609C→T Polymorphism in the NAD(P)H:Quinone Oxidoreductase (NQO1) Gene in Patients With Primary and Therapy-Related Myeloid Leukemia
Larson, R. A., Wang, Y., Banerjee, M., et al. (1999) · Blood · doi:10.1182/blood.v94.2.803.414k44_803_807 · Cited by 27 · see citing works
Leukemia incidence following primary breast carcinoma treatment
Kaplan, H. G., Malmgren, J. A., & Atwood, M. K. (2004) · Cancer · doi:10.1002/cncr.20475 · Cited by 26 · see citing works
Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome
Offman, J., Gascoigne, K. E., Bristow, F., Macpherson, P., Bignami, M., Casorelli, I., Leone, G. G. M., Pagano, L., Sica, S., Halil, O., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0182 · Cited by 24 · see citing works
Self-citation
High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia
Milligan, D. W., Kochethu, G., Dearden, C. E., Matutes, E., MacConkey, C., & Catovsky, D. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05982.x · Cited by 23 · see citing works
Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group
Pagano, L., Pulsoni, A., Mele, L., Tosti, M. E., Cerri, R., Visani, G., Melillo, L. M. A., Candoni, A., Clavio, M., Nosari, A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1008318816244 · Cited by 23 · see citing works
Self-citation
Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion
Sterkers, Y., Preudhomme, C., Laï, J., et al. (1998) · Blood · doi:10.1182/blood.v91.2.616.616_616_622 · Cited by 23 · see citing works
Ionizing radiation and leukaemia: more questions than answers
Wright, E. G. (2005) · Hematological Oncology · doi:10.1002/hon.763 · Cited by 21 · see citing works
Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukaemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials
Pagano, L., Annino, L., Ferrari, A., Camera, A., Martino, B., Montillo, M., Tosti, M. E., Mele, A., Pulsoni, A., Vegna, M. L., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00616.x · Cited by 17 · see citing works
Self-citation
Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
Rauscher, G. H., Sandler, D. P., Poole, C., Pankow, J. S., Shore, D., Bloomfield, C. D., & Olshan, A. F. (2003) · PubMed · Cited by 16 · see citing works
Risk Stratification for Survival and Leukemic Transformation in Essential Thrombocythemia: A Single Institutional Study of 605 Patients.
Gangat, N., Wolanskyj, A. P., McClure, R. F., Li, C. Y., Schwager, S. M., Wu, W., & Tefferi, A. (2006) · Blood · doi:10.1182/blood.v108.11.3599.3599 · Cited by 9 · see citing works
Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 114 adult patients
Rund, D. G., Krichevsky, S., Cohen, S. B., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran‐Tikva, S., Ben‐Neriah, S., & Ben‐Yehuda, D. (2009) · Hematology Meeting Reports (formerly Haematologica Reports) · doi:10.4081/hmr.v2i15.610 · Cited by 5 · see citing works
Self-citation

Flagged first, then by citations

Research works printed but not linked: 4

Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 1998;95:13176-81.
Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, et al. Acute myeloid leukemia in children treated with epipodophillotoxins for acute lymphocytic leukemia. N Engl J Med 2001;325,1682-7.
Cuzick J, Erskine S, Edelman D, Galton DA. A comparison of the inci- dence of the myelodisplasic syndrome and acute myeloid leukemia following melphalan and cyclophosphamide treatement for myelomatosis. Br J Cancer 1987;55:523-9.
Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, et al. Hydroxyurea compared with anagre- lide in high-risk essential thrombocy- themia. N Engl J Med 2005;353: 33-45.

Sorted by citations

Osteosarcoma
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Bhatt, V. R., Bixby, D. L., Blum, W. G., Coutre, S. E., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0116 · Cited by 648 · see citing works
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D. L., Coutre, S. E., Lima, M. J. G. D., Fathi, A. T., Fiorella, M., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0028 · Cited by 423 · see citing works
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Takahashi, K., Wang, F., Kantarjian, H., Doss, D., Khanna, K., Thompson, E., Zhao, L., Patel, K., Neelapu, S., Gumbs, C., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30626-x · Cited by 399 · see citing works
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
Wood, M. E., Vogel, V. G., Ng, A. K., Foxhall, L. E., Goodwin, P. J., & Travis, L. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8681 · Cited by 323 · see citing works
Acute Myeloid Leukemia
O'Donnell, M. R., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Attar, E. C., Borate, U., Coutre, S. E., Damon, L. E., Goorha, S., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0103 · Cited by 323 · see citing works
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Lustberg, M. B., Kuderer, N. M., Desai, A. P., Bergerot, C. D., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 331 · see citing works
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Travis, L. B., Demark‐Wahnefried, W., Allan, J. M., Wood, M. E., & Ng, A. K. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.41 · Cited by 264 · see citing works
Cancer Incidence in Systemic Sclerosis: Meta‐Analysis of Population‐Based Cohort Studies
Ōnishi, A., Sugiyama, D., Kumagai, S., & Morinobu, A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37969 · Cited by 188 · see citing works
Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
Lyman, G. H., Dale, D. C., Wolff, D. A., Culakova, E., Poniewierski, M. S., Kuderer, N. M., & Crawford, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8723 · Cited by 182 · see citing works
Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L
Chen, D.-H., Below, J. E., Shimamura, A., Keel, S., Matsushita, M. M., Wolff, J., Sul, Y., Bonkowski, E. S., Castellà, M., Taniguchi, T., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.009 · Cited by 178 · see citing works
Hepatosplenic T cell lymphoma in inflammatory bowel disease: Table 1
Shale, M., Kanfer, E., Panaccione, R., & Ghosh, S. K. (2008) · Gut · doi:10.1136/gut.2008.163279 · Cited by 158 · see citing works
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
Fishbein, L. M., Rivero, J. D., Else, T., Howe, J. R., Asa, S. L., Cohen, D. L., Dahia, P. L. M., Fraker, D. L., Goodman, K. A., Hope, T. A., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001792 · Cited by 156 · see citing works
Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study
Olesen, A. B., Sværke, C., Farkas, D. K., & Sørensen, H. T. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09861.x · Cited by 149 · see citing works
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects
Nardo, P. D., Lisanti, C., Garutti, M., Buriolla, S., Alberti, M., Mazzeo, R., & Puglisi, F. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2151584 · Cited by 157 · see citing works
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group
Eichenauer, D. A., Thielen, I., Haverkamp, H., Franklin, J. G., Behringer, K., Halbsguth, T. V., Klimm, B. C., Diehl, V., Sasse, S., Rothe, A., et al. (2014) · Blood · doi:10.1182/blood-2013-07-512657 · Cited by 139 · see citing works
Ophthalmic manifestations of leukemia
Talcott, K. E., Garg, R. J., & Garg, S. J. (2016) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000309 · Cited by 130 · see citing works
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues
Hijiya, N., Ness, K. K., Ribeiro, R. C., & Hudson, M. M. (2008) · Cancer · doi:10.1002/cncr.23988 · Cited by 118 · see citing works
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Boddu, P., Kantarjian, H. M., Garcia-Manero, G., Ravandi, F., Verstovsek, S., Jabbour, E., Borthakur, G., Konopleva, M., Bhalla, K. N., Daver, N., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017008227 · Cited by 112 · see citing works
Incidence and susceptibility to therapy-related myeloid neoplasms
Leone, G. G. M., Fianchi, L., Pagano, L., & Voso, M. T. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.12.013 · Cited by 104 · see citing works
Self-citation
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia
Qian, Z., Joslin, J. M., Tennant, T. R., Reshmi, S. C., Young, D. J., Stoddart, A., Larson, R. A., & Beau, M. M. L. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.11.025 · Cited by 103 · see citing works
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
Steensma, D. P. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0140-3 · Cited by 98 · see citing works
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
Elter, T., Gercheva, L., Pylylpenko, H., Robak, T., Jaksic, B. S., Rekhtman, G. B., Kyrcz‐Krzemień, S., Vatutin, M. T., Wu, J., Sirard, C. A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70242-x · Cited by 92 · see citing works
Diagnosis and treatment of therapy-related acute myeloid leukemia
Strickland, S. A., & Vey, N. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103607 · Cited by 92 · see citing works
A review of the potential association between childhood leukemia and benzene
Pyatt, D. W., & Hays, S. M. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.002 · Cited by 76 · see citing works
ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
Grosjean-Raillard, J., Tailler, M., Adès, L., Perfettini, J., Fabre, C., Braun, T., de Botton, S., Fenaux, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.457 · Cited by 74 · see citing works
Acute myeloid leukemia developing in patients with autoimmune diseases
Ramadan, S. M., Fouad, T. M., Summa, V., Hasan, S. K., & Lo‐Coco, F. (2011) · Haematologica · doi:10.3324/haematol.2011.056283 · Cited by 73 · see citing works
Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma
Hasskarl, J., Ihorst, G., Pasquale, D. D., Schröttner, P., Zerweck, A., Wäsch, R., & Engelhardt, M. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.529207 · Cited by 71 · see citing works
Myelodysplastic syndromes: biology and treatment
Jädersten, M., & Hellström‐Lindberg, E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02052.x · Cited by 65 · see citing works
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report
Morton, L. M., Saber, W., Baker, K. S., Barrett, A. J., Bhatia, S., Engels, E. A., Gadalla, S. M., Kleiner, D. E., Pavletic, S. Z., & Burns, L. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.005 · Cited by 65 · see citing works
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases
Shivakumar, R., Tan, W., Wilding, G. E., Wang, E. S., & Wetzler, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn182 · Cited by 63 · see citing works
Blood disorders typically associated with renal transplantation
Yu, Y., Yu, B., & Chen, Y. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00018 · Cited by 61 · see citing works
Therapy-related myeloid neoplasms
Leone, G. G. M., Fianchi, L., & Voso, M. T. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834bcc2a · Cited by 58 · see citing works
Self-citation
The risk of cancer development in systemic sclerosis: A meta-analysis
Zhang, J., Wan, Y.-N., Peng, W., Yan, J., Li, B., Mei, B., Chen, B., Yao, H. C., Yang, G., Tao, J., et al. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.04.014 · Cited by 56 · see citing works
Systemic Sclerosis Association with Malignancy
Lepri, G., Catalano, M., Bellando-Randone, S., Pillozzi, S., Giommoni, E., Giorgione, R., Botteri, C., Matucci‐Cerinic, M., Antonuzzo, L., & Guiducci, S. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08930-4 · Cited by 53 · see citing works
Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes
Foran, J. M., & Shammo, J. M. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.04.015 · Cited by 52 · see citing works
Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs
Mahmoodi, M., Soleymanjahi, S., Zendehdel, K., Mozdarani, H., Azimi, C., Farzanfar, F., Safari, Z., Mohagheghi, M. A., Khaleghian, M., Divsalar, K., et al. (2016) · Drug and Chemical Toxicology · doi:10.1080/01480545.2016.1209678 · Cited by 49 · see citing works
Myeloid disorders after autoimmune disease
Boddu, P. C., & Zeidan, A. M. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.002 · Cited by 48 · see citing works
Changes of Reactive Oxygen and Nitrogen Species and Mitochondrial Functioning in Human K562 and HL60 Cells Exposed to Ionizing Radiation
Saenko, Y., Cieślar‐Pobuda, A., Skonieczna, M., & Rzeszowska‐Wolny, J. (2013) · Radiation Research · doi:10.1667/rr3247.1 · Cited by 46 · see citing works
TNF-α Regulates the Effects of Irradiation in the Mouse Bone Marrow Microenvironment
Cachaço, A. S., Carvalho, T., SANTOS, A. C. D. S., Igreja, C., Fragoso, R., Osório, C., Ferreira, M. M., Serpa, J., Correia, S., Pinto‐do‐Ó, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008980 · Cited by 44 · see citing works
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome
Porta, M. G. D., & Malcovati, L. (2009) · Haematologica · doi:10.3324/haematol.2009.005702 · Cited by 44 · see citing works
Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children
Gökçe, M., Bilginer, Y., Beşbaş, N., Özaltın, F., Cetin, M., Gümrük, F., & Özen, S. (2012) · Lupus · doi:10.1177/0961203312443721 · Cited by 45 · see citing works
Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers
Löfström, B., Backlin, C., Sundström, C., Hellström‐Lindberg, E., Ekbom, A., & Lundberg, I. E. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep204 · Cited by 42 · see citing works
Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview
Eastmond, D. A., Keshava, N., & Sonawane, B. R. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.04.001 · Cited by 42 · see citing works
Therapy-related myeloid neoplasms following treatment with radioiodine
Schroeder, T. A., Kuendgen, A., Käyser, S., Kröger, N. M., Braulke, F., Platzbecker, U., Klärner, V., Zohren, F., Haase, D. T., Stadler, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.049114 · Cited by 38 · see citing works
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
Joannides, M., Mays, A. N., Mistry, A. R., Hasan, S. K., Reiter, A., Wiemels, J. L., Felix, C. A., Lo‐Coco, F., Osheroff, N., Solomon, E., et al. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.045 · Cited by 35 · see citing works
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
Valentini, C. G., Fianchi, L., Voso, M. T., Caira, M., Leone, G. G. M., & Pagano, L. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.069 · Cited by 34 · see citing works
Self-citation
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors
Lutzmann, M., Bernex, F., de Jesus, C. D. C., Hodroj, D., Marty, C., Plo, I., Vainchenker, W., Tosolini, M., Forichon, L., Bret, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.095 · Cited by 33 · see citing works
Second malignancies after breast cancer: The impact of adjuvant therapy
Dong, C., & Chen, L. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.250 · Cited by 33 · see citing works
Secondary acute myeloid leukemia – a single center experience
Szotkowski, T., Rohoň, P., Zapletalova, L., Sičová, K., Hubácek, J., & Indrák, K. (2010) · Neoplasma · doi:10.4149/neo_2010_02_170 · Cited by 32 · see citing works
Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma
Ojha, R. P., Fischbach, L. A., Zhou, Y., Felini, M., Singh, K. P., & Thertulien, R. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.04.003 · Cited by 30 · see citing works
Secondary Acute Myeloid Leukemia
Winer, E. S. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.003 · Cited by 29 · see citing works
Two-Mechanism Model for the Interaction of Etoposide Quinone with Topoisomerase IIα
Gibson, E. G., King, M. M., Mercer, S. L., & Deweese, J. E. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00209 · Cited by 29 · see citing works
Challenges in the diagnosis and treatment of secondary acute myeloid leukemia
Ossenkoppele, G. J., & Montesinos, P. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.03.003 · Cited by 28 · see citing works
Acute myeloid leukaemia in W estern A ustralia 1991–2005: a retrospective population‐based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome
Gangatharan, S. A., Grove, C. S., P’ng, S., O'Reilly, J., Joske, D. J. L., Leahy, M. F., Threlfall, T. J., & Wright, M. P. (2013) · Internal Medicine Journal · doi:10.1111/imj.12169 · Cited by 28 · see citing works
Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications
May, J. E., Donaldson, C., Gynn, L. E., & Morse, H. (2018) · Mutagenesis · doi:10.1093/mutage/gey014 · Cited by 27 · see citing works
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes
Fabiani, E., D’Alò, F., Scardocci, A., Greco, M., Ruscio, A. D., Criscuolo, M., Fianchi, L., Pagano, L., Hohaus, S., Leone, G. G. M., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.10.012 · Cited by 26 · see citing works
Self-citation
Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH
Itzhar-Baïkian, N., Dessen, P., Toujani, S., Auger, N., Preudhomme, C., Richon, C., Lazar, V., Saada, V., Griscelli, A. B., Bourhis, J. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016623 · Cited by 26 · see citing works
Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1–MDS1–EVI1 fusion transcript
Park, T. S., Choi, J. R., Yoon, S. H., Song, J., Kim, J., Kim, S. J., Kwon, O., & Min, Y. H. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.06.015 · Cited by 25 · see citing works
Myelodysplastic Syndromes (MDS)
Pleyer, L., Neureiter, D., Faber, V., & Greil, R. (2010) · Springer eBooks · doi:10.1007/978-3-211-79892-8_6 · Cited by 24 · see citing works
Radiotherapy- and Chemotherapy-Induced Myelodysplasia Syndrome
Sun, L.-M., Lin, C., Lin, M., Liang, J., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000000737 · Cited by 24 · see citing works
Cytotoxic effects of catechol to neuroblastoma N2a cells.
Lima, R. M. F., Alvarez, L. D. G., Costa, M. F. D., Costa, S. L., Clarêncio, J., & El-Bachá, R. D. S. (2008) · PubMed · Cited by 24 · see citing works
Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research
members, O. B. O. T. E. W. E. A. I. O., Pelkonen, O., Terron, A., Hernández, A. F., Menéndez, P. R., & Bennekou, S. H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1986-x · Cited by 24 · see citing works
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis
Franklin, J. G., Eichenauer, D. A., Becker, I., Monsef, I., & Engert, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008814.pub2 · Cited by 24 · see citing works
The molecular basis of familial chronic lymphocytic leukemia
Crowther-Swanepoel, D., & Houlston, R. S. (2009) · Haematologica · doi:10.3324/haematol.2009.006296 · Cited by 22 · see citing works
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation
Rodríguez‐Sevilla, J. J., Ademà, V., Garcia‐Manero, G., & Colla, S. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100940 · Cited by 23 · see citing works
Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes
Kim, M., & Williams, S. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018764923 · Cited by 21 · see citing works
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma
Calip, G. S., Moran, K. M., Sweiss, K. I., Patel, P. R., Wu, Z., Adimadhyam, S., Lee, T. A., Ko, N. Y., Quigley, J. G., & Chiu, B. C. ‐. (2018) · Cancer · doi:10.1002/cncr.31914 · Cited by 21 · see citing works
Acute Myelogenous Leukemia and Myelodysplasia Secondary to Breast Cancer Treatment: Case Studies and Literature Review
Cole, M. E., & STRAIR, R. K. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181bedb74 · Cited by 21 · see citing works
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models
Duong, V. H., Lancet, J. E., Alrawi, E., Al‐Ali, N., Perkins, J. B., Field, T. L., Epling‐Burnette, P. K., Zhang, L., List, A. F., & Komrokji, R. S. (2013) · Leukemia Research · doi:10.1016/j.leukres.2012.12.012 · Cited by 20 · see citing works
Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms
Jeyaratnam, D. C., Baduin, B. S., Hansen, M. H., Hansen, M., Jørgensen, J. M., Aggerholm, A., Ommen, H. B., Hokland, P., & Nyvold, C. G. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.02.005 · Cited by 19 · see citing works
Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features
Wang, S. A., Abruzzo, L. V., Hasserjian, R. P., Zhang, L., Hu, Y., Zhang, Y., Zhao, M., Galili, N., Raza, A., Medeiros, L. J., et al. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.07.018 · Cited by 18 · see citing works
Impact of first- and second-line treatment for Hodgkin’s lymphoma on the incidence of AML/MDS and NHL—experience of the German Hodgkin’s Lymphoma Study Group analyzed by a parametric model of carcinogenesis
Scholz, M. R., Engert, A., Franklin, J. G., Josting, A., Diehl, V., Hasenclever, D., & Loeffler, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq408 · Cited by 17 · see citing works
Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms
Diamond, H. R., Ornellas, M. H., Órfão, A., Gomes, B. E., Campos, M. M., Fernandez, T. D. S., da Silva, R. I., Alves, G., Lage, C. A. S., Da, S., et al. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-39 · Cited by 17 · see citing works
High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study
Kamat, N., Khidhir, M. A., Jaloudi, M., Hussain, S., Alashari, M., Qawasmeh, K. H. A. A., & Rannug, U. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-373 · Cited by 17 · see citing works
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
Sasaki, K., Jabbour, E. J., Cortes, J. E., Kadia, T. M., Garcia‐Manero, G., Borthakur, G. M., Jain, P., Pierce, S. A., Daver, N. G., Takahashi, K., et al. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.08.015 · Cited by 17 · see citing works
Long-Term Outcomes of Myeloid Growth Factor Treatment
Lyman, G. H., & Dale, D. C. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0077 · Cited by 16 · see citing works
Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients
Kamat, N., Khidhir, M. A., Hussain, S., Alashari, M., & Rannug, U. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0118-4 · Cited by 15 · see citing works
Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia
Olme, C.-H., Finnon, R., Brown, N., Kabacik, S., Bouffler, S. D., & Badie, C. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.019 · Cited by 15 · see citing works
Azacitidine in the Treatment of Pediatric Therapy-related Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Inoue, A., Kawakami, C., Takitani, K., & Tamai, H. (2014) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000042 · Cited by 15 · see citing works
Secondary Acute Myeloid Leukemia in Survivors of Hodgkin Lymphoma
Bhatt, V. R., Giri, S., Verma, V., Dahal, S., Shah, B. K., Pathak, R., Bociek, R. G., Vose, J. M., & Armitage, J. O. (2016) · Future Oncology · doi:10.2217/fon-2016-0048 · Cited by 15 · see citing works
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation
Pullarkat, V. A., Slovak, M. L., Dagis, A., Bedell, V., Somlo, G., Nakamura, R., Stein, A. S., O’Donnell, M., Nademanee, A., Teotico, A. L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp232 · Cited by 14 · see citing works
Effects of Lifestyle and Environmental Factors on the Risk of Acute Myeloid Leukemia: Result of a Hospital-based Case-Control Study
Behzad, M. M., Abbasi, M., Oliaei, I., Ghorbani, S., & Rafieemehr, H. (2021) · Journal of Research in Health Sciences · doi:10.34172/jrhs.2021.58 · Cited by 14 · see citing works
Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification
Racke, F. K., Cole, C., Walker, A., Jones, J. A., & Heerema, N. A. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.11.001 · Cited by 13 · see citing works
Therapy‐related leukemia following chemoradiotherapy for esophageal cancer
Mimura, N., Tsujimura, H., Ise, M., Sakai, C., Takagi, T., Nagata, M., & Kumagai, K. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01487.x · Cited by 13 · see citing works
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia
Cafaro, A., Giannini, M. B., Silimbani, P., Cangini, D., Masini, C., di Rorà, A. G. L., Simonetti, G., Martinelli, G., & Cerchione, C. (2020) · Minerva Medica · doi:10.23736/s0026-4806.20.07017-2 · Cited by 13 · see citing works
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)
Slovak, M. L., Bedell, V., Lew, D. L., Albain, K. S., Ellis, G. K., Livingston, R. B., Martino, S., Perez, E. A., Hortobágyi, G. N., Sher, D., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0597-5 · Cited by 13 · see citing works
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
Stoddart, A., McNerney, M. E., Bartom, E. T., Bergerson, R. J., Young, D. J., Qian, Z., Wang, J., Fernald, A. A., Davis, E. M., Larson, R. A., et al. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.019 · Cited by 13 · see citing works
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs
Cordone, I., Amodeo, R., Bellesi, S., Bottan, F., Buccisano, F., Propris, M. S. D., Masi, S., Panichi, V., Scerpa, M. C., Annibali, O., et al. (2023) · Cancers · doi:10.3390/cancers15072060 · Cited by 11 · see citing works
Polymorphic variants ofGSTM1,GSTT1, andGSTP1genes in childhood acute leukemias: A preliminary study in Argentina
Weich, N., Núñez, M., Galimberti, G., Elena, G. D. C. R. P., Acevedo, S., Larripa, I. B., & Fundia, A. F. (2015) · Hematology · doi:10.1179/1607845415y.0000000007 · Cited by 11 · see citing works
Aptamers for DNA Damage and Repair
McKeague, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102212 · Cited by 11 · see citing works
Secondary acute promyelocytic leukemia following chemotherapy for gastric cancer: A case report
Zhang, Y.-C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4402 · Cited by 11 · see citing works
Acute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma.
Gonzalez, M. M., Kidd, L. R., Quesada, J. R., Nguyen, N., & Chen, L. (2013) · PubMed · Cited by 11 · see citing works
Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis
Boquoi, A., Banahan, S. M., Mohring, A., Savickaite, I., Strapatsas, J., Hildebrandt, B., Kobbe, G., Gattermann, N., Haas, R. R., Schroeder, T. A., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04775-1 · Cited by 10 · see citing works
Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study
Wang, Z., Yin, Y., Wang, J., Zhu, Y., Li, X., & Zeng, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.716741 · Cited by 10 · see citing works
Altered chromatin modifications in AML1/RUNX1 breakpoint regions involved in (8;21) translocation
Stuardo, M., Martínez, M., Hidalgo, K., Montecino, M. A., Javed, A., Lian, J. B., Stein, G. S., Stein, J. L., & Gutierrez, S. E. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21599 · Cited by 10 · see citing works
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy
Zimmerman, Z. F., Scott, B. L., Gopal, A. K., Sandmaier, B. M., Maloney, D. G., & Deeg, H. J. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.180 · Cited by 10 · see citing works
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
Papanikolaou, X. D., Barlogie, B., & Usmani, S. Z. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.047 · Cited by 9 · see citing works
Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor
Shim, H., Chi, H., Jang, S., Seo, E., Park, C., Lee, J., Lee, J., & Lee, K. (2010) · The Korean Journal of Hematology · doi:10.5045/kjh.2010.45.3.177 · Cited by 9 · see citing works
Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy
Patel, S. A. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5617 · Cited by 9 · see citing works

Correspondence:
Pagano, L., Ben-yehuda, D., Voso, M. T., Cattolica, U., Cuore, S., & Di, I. (2015)
Self-citation
Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
Brunning, R. D. (1992) · Springer eBooks · doi:10.1007/978-3-642-75952-9_14 · Cited by 2 · see citing works
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Bhatia, R. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.013 · Cited by 220 · see citing works
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., Andersson, M. V., Daugaard, G., Ersbøll, J., Sw, H., HOU-JENSEN, K., Nielsen, D. L., & Sigsgaard, T. (1993) · PubMed · Cited by 181 · see citing works
PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM
Larson, R. A., & Beau, M. L. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.032 · Cited by 32 · see citing works

Authors: Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T.
Affiliations: Università Cattolica del Sacro Cuore (IT)
Corresponding author: Leone, G.
ORCID: Leone, G.
Pagano, L.
Voso, M. T.
Venue: Haematologica
Publisher: Ferrata Storti Foundation (Haematologica)
Published: 2007-10-01
Volume: 92
Issue: 10
Pages: 1389-1398
ISSN: 0390-6078 (ISSN-L)
1592-8721
DOI: 10.3324/haematol.11034
OpenAlex: W2148305047
Cited by: 236
References: 73
Citations by year: 2026: 9 · 2025: 6 · 2024: 4 · 2023: 9 · 2022: 16 · 2021: 15 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 12 · 2015: 16 · 2014: 15 · 2013: 15 · 2012: 19
FWCI: 10.79
Type: journal article
Language: en
Open access: gold
doi.org
Locations: Haematologica (publishedVersion)
PubMed (publishedVersion)
Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords: therapy-related myelodysplastic syndrome, therapy-related acute myeloid leukemia, secondary malignancies, alkylating agents, topoisomerase II inhibitors, azathioprine, DNA mismatch repair, 11q23 translocation, Hodgkin's disease, non-Hodgkin lymphoma, total body irradiation, autologous stem cell transplantation, granulocyte colony-stimulating factor, acute lymphoblastic leukemia, breast cancer, germ cell tumors, genetic susceptibility, polymorphism
MeSH terms: Animals, Disease Susceptibility, DNA, DNA Topoisomerases, Type II, DNA Repair, Humans, Leukemia, Myelodysplastic Syndromes, Polymorphism, Genetic, Radiotherapy, Risk Factors, Incidence, Topoisomerase II Inhibitors, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Therapy-related leukemia and myelodysplasia: susceptibility and incidence

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks